Institut des Sciences Moléculaires d'Orsay

Unité mixte CNRS/Université Paris-Saclay

Slide 1
Slide 2
Slide 3
Slide 4
Slide 5
Slide 6
Slide 7
Slide 8
Slide 9

 Events, news.

Highlights ! 

MOOC Nano 2025

9th session of the MOOC: ‘Understanding Nanosciences’ by the University of Paris-Saclay and the Labex NanoSaclay.
Courses start on April 28th.

Production and characterization of short gas pulses in supersonic expansions

Hansjürg Schmutz & Joseph Agner
ETH Zürich

Tuesday, April 29

Development of crystallization control technique for organic materials using femtosecond laser

Yuka TSURI
Div. of Materials Science, NAIST

Wednesday, March 12, 11 a.m.

Marie-Aline Martin’s Habilitation to Supervise Research

Spectroscopie moléculaire à haute résolution des micro-ondes à l’infrarouge: Applications en physique moléculaire et astrophysique

Friday, March 7, at 10:45 AM, in the ISMO Amphitheater.

Efficient first-principles exploration on the physical and chemical space of peptides and saccharides enabled by neural network potentials

Jer-Lai Kuo
Academi Sinica, M3 Lab, Institute of Atomic and Molecular Sciences, Taiwan
Jeudi 16 janvier, 11h

Single molecules at the atomic scale: excitons and trions, circumstellar analogues and on-surface catalysis

Pablo Merino
Material Science Institute of Madrid (ICMM-CSIC)

Mardi 11 février, 11h

Unraveling astrochemical reaction mechanisms through sequential ion-molecule reactions

Heather Lewandowski
JILA Faculty, University of Colorado-Boulder

Lundi 3 février, 11h

Nonlinear processes in condensed matter driven by Terahertz fields

Ahmed Ghalgaoui
Department of Physics, Dortmund University

Mardi 4 février, 11h

Production and characterization of short gas pulses in supersonic expansions

Hansjürg Schmutz & Joseph Agner
ETH Zürich

Tuesday, April 29

Proof of concept for the combination of Gemcitabine-loaded MOF and hadrontherapy to treat hypoxic cancers

In a study published in the International Journal of Pharmaceutics, ISMO researchers have published the first study of an innovative strategy that combines porous organometallic nanoparticles (nanoMOFs) loaded with the anti-cancer drug Gemcitabine monophosphate (GemMP) and helium and carbon ion hadrontherapy.